Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with ACE inhibitors.

A M Breckenridge1

  • 1Department of Pharmacology and Therapeutics, University of Liverpool, UK.

Journal of Human Hypertension
|June 1, 1989
PubMed
Summary

Angiotensin-converting enzyme (ACE) inhibitors interact with diuretics and other blood pressure medications. Specific interactions, like captopril-digoxin, affect drug clearance, while bradykinin interactions may cause cough or rash.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions.

Clinical pharmacology and therapeutics·2015
Same author

The burden of alcohol misuse on an inner-city general hospital.

QJM : monthly journal of the Association of Physicians·2000
Same author

The pharmacokinetics of combination therapy with nelfinavir plus nevirapine.

AIDS (London, England)·1998
Same author

Clinical pharmacology and malaria.

Annals of tropical medicine and parasitology·1998
Same author

Adverse drug reactions.

BMJ (Clinical research ed.)·1998
Same author

Reporting adverse drug reactions in HIV infection.

Genitourinary medicine·1998

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are widely used for hypertension and heart failure.
  • Understanding their drug interactions and effects of organ dysfunction is crucial for safe and effective therapy.

Purpose of the Study:

  • To review common and specific drug interactions associated with ACE inhibitors.
  • To examine the impact of renal and hepatic impairment on ACE inhibitor pharmacokinetics and pharmacodynamics.

Main Methods:

  • Literature review of published studies on ACE inhibitor drug interactions.
  • Analysis of pharmacokinetic and pharmacodynamic data related to organ dysfunction.

Main Results:

  • Common interactions include those with thiazide diuretics and other antihypertensives.
  • Specific interactions: captopril-digoxin (decreased digoxin clearance), captopril-probenecid (decreased captopril clearance).
  • Bradykinin metabolism by ACE inhibitors may lead to cough, rash, and interaction with NSAIDs like indomethacin (enalapril and lisinopril may differ). Renal dysfunction necessitates dose reduction; hepatic impairment has less clinical significance.

Conclusions:

  • ACE inhibitors have significant drug interactions and their use requires careful consideration of patient's renal function.
  • Awareness of these interactions is vital for optimizing patient outcomes and minimizing adverse events.

Related Experiment Videos